Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse

Amanda J Griffin1, Lin-Xi Li, Sabrina Voedisch

  • 1Center for Infectious Diseases and Microbiology Translational Research, Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, McGuire Translational Research Facility, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Infection and Immunity
|January 26, 2011
PubMed

Insights

A new animal model reveals how typhoid relapses after antibiotic treatment. Mesenteric lymph nodes act as a reservoir, but also protect against infection spread.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Relapsing enteric infections pose a clinical challenge.
  • Lack of suitable animal models impedes understanding of relapse mechanisms.

Purpose of the Study:

  • To develop and characterize a robust animal model for studying relapsing typhoid.
  • To identify host factors and reservoirs contributing to typhoid relapse after antibiotic treatment.

Main Methods:

  • Established a mouse model of primary typhoid using Salmonella.
  • Administered enrofloxacin antibiotic treatment and monitored bacterial loads and clinical outcomes.
  • Utilized in vivo imaging to track Salmonella dissemination.
  • Employed magnetic-bead enrichment to isolate and analyze immune cells from mesenteric lymph nodes (MLNs).

Main Results:

  • Antibiotic treatment reduced bacterial loads but did not prevent relapse upon therapy interruption.
  • Mesenteric lymph nodes (MLNs) were identified as a key reservoir for persistent Salmonella.
  • A specific monocyte subset (CD11b(+) Gr-1(-)) in MLNs harbored low bacterial numbers.
  • MLN removal exacerbated typhoid relapse, indicating a protective role.

Conclusions:

  • The developed model effectively replicates relapsing typhoid in mice.
  • MLNs serve a dual role in typhoid relapse: as a bacterial reservoir and a protective filter against systemic spread.
  • Specific intestinal phagocytes in MLNs are involved in controlling bacterial dissemination during antibiotic therapy.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Reservoir of Infection01:30

Reservoir of Infection

Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...